Notice of Applications for Deregistration Under Section 8(f) of the Investment Company Act of 1940, 18739 [2014-07471]

Download as PDF Federal Register / Vol. 79, No. 64 / Thursday, April 3, 2014 / Notices created by Congress to advance the mission of FDA to modernize medical, veterinary, food, food ingredient, and cosmetic product development; accelerate innovation; and enhance product safety. With the ultimate goal of improving public health, the Foundation provides a unique opportunity for different sectors (FDA, patient groups, academia, other government entities, and industry) to work together in a transparent way to create exciting new research projects to advance regulatory science. The Foundation acts as a neutral third party to establish novel, scientific collaborations. Much like any other independently developed information, FDA evaluates the scientific information from these collaborations to determine how Reagan-Udall Foundation projects can help the Agency to fulfill its mission. The Foundation’s projects include: The Innovation in Medical Evidence Development and Surveillance (IMEDS) Program, methods for using observational electronic health care data for postmarket evidence generation, including postmarket safety surveillance; the Systems Toxicology Project, an evaluation of a systems biology approach to preclinical safety testing; and the Critical Path to Tuberculosis Multidrug Regimens (CPTR) Project, looking at new ways to develop tuberculosis combination therapies. The Foundation seeks comments on these and other potential topics for future activities. II. Agenda The Foundation will be providing an overview of its history, project updates, as well as projected activities going forward. Find the Meeting Agenda at https://www.ReaganUdall.org. Dated: March 31, 2014. Jane Reese-Coulbourne, Executive Director, Reagan-Udall Foundation for the FDA. [FR Doc. 2014–07484 Filed 4–2–14; 8:45 am] BILLING CODE 4164–04–P 2014. A copy of each application may be obtained via the Commission’s Web site by searching for the file number, or for an applicant using the Company name box, at https://www.sec.gov/search/ search.htm or by calling (202) 551– 8090. An order granting each application will be issued unless the SEC orders a hearing. Interested persons may request a hearing on any application by writing to the SEC’s Secretary at the address below and serving the relevant applicant with a copy of the request, personally or by mail. Hearing requests should be received by the SEC by 5:30 p.m. on April 22, 2014, and should be accompanied by proof of service on the applicant, in the form of an affidavit or, for lawyers, a certificate of service. Hearing requests should state the nature of the writer’s interest, the reason for the request, and the issues contested. Persons who wish to be notified of a hearing may request notification by writing to the Secretary, U.S. Securities and Exchange Commission, 100 F Street NE., Washington, DC 20549–1090. For Further Information Contact: Diane L. Titus at (202) 551–6810, SEC, Division of Investment Management, Chief Counsel’s Office, 100 F Street NE., Washington, DC 20549–8010. Lazard Alternative Strategies Fund, L.L.C. [File No. 811–10415] [Release No. IC–30998] pmangrum on DSK3VPTVN1PROD with NOTICES Dreyfus Money Market Instruments Inc. [File No. 811–2557] Summary: Applicant seeks an order declaring that it has ceased to be an investment company. On March 7, 2013, applicant made a final liquidating distribution to its shareholders based on net asset value. Expenses of $1,897 incurred in connection with the reorganization were paid by The Dreyfus Corporation, applicant’s investment adviser. March 28, 2014. The following is a notice of applications for deregistration under section 8(f) of the Investment Company Act of 1940 for the month of March VerDate Mar<15>2010 15:17 Apr 02, 2014 Jkt 232001 Filing Dates: The application was filed on January 15, 2014, and amended on March 21, 2014. Applicant’s Address: c/o The Dreyfus Corporation, 200 Park Ave., New York, NY 10166. ING Emerging Markets Local Bond Fund [File No. 811–22505]; ING Global Strategic Income Fund [File No. 811– 22681] Summary: Each applicant, a closedend investment company, seeks an order declaring that it has ceased to be an investment company. Applicants have never made a public offering of their securities and do not propose to make a public offering or engage in business of any kind. Filing Date: The applications were filed on March 7, 2014. Applicants’ Address: 7337 E Doubletree Ranch Rd., suite 100, Scottsdale, AZ 85258. For the Commission, by the Division of Investment Management, pursuant to delegated authority. Kevin M. O’Neill, Deputy Secretary. [FR Doc. 2014–07471 Filed 4–2–14; 8:45 am] BILLING CODE 8011–01–P SECURITIES AND EXCHANGE COMMISSION [Release No. IC–30999; File No. 812–14203] Summary: Applicant, a closed-end investment company, seeks an order declaring that it has ceased to be an investment company. Applicant transferred its assets to Lazard Alternative Strategies 1099 Fund, and on December 31, 2013, made a distribution to its shareholders based on net asset value. Expenses of $200,000 incurred in connection with the reorganization were paid by Lazard Asset Management LLC, applicant’s investment adviser. Filing Dates: The application was filed on January 30, 2014, and amended on March 26, 2014. Applicant’s Address: 30 Rockefeller Plaza, New York, NY 10112–6300. SECURITIES AND EXCHANGE COMMISSION Notice of Applications for Deregistration Under Section 8(f) of the Investment Company Act of 1940 18739 PO 00000 Frm 00077 Fmt 4703 Sfmt 4703 Minnesota Life Insurance Company, et al.; Notice of Application March 28, 2014. Securities and Exchange Commission (‘‘SEC’’ or ‘‘Commission’’). ACTION: Notice of application for an order approving the substitution of certain securities pursuant to Section 26(c) of the Investment Company Act of 1940, as amended (the ‘‘1940 Act’’ or ‘‘Act’’) and an order of exemption pursuant to Section 17(b) of the Act from Section 17(a) of the Act. AGENCY: Minnesota Life Insurance Company (‘‘Minnesota Life’’), Variable Annuity Account (‘‘VAA’’), Minnesota Life Variable Life Account (‘‘VLI’’), Minnesota Life Variable Universal Life Account (‘‘VGUL’’), Group Variable Universal Life Account (‘‘Private VGUL I’’), Variable Universal Life Account II (‘‘Private VGUL II’’), Securian Life Insurance Company (‘‘Securian Life’’), and Securian Life Variable Universal Life Account (‘‘SVGUL’’). Minnesota Life and Securian Life are referred to individually as a ‘‘Life Company’’ and collectively as ‘‘Life Companies.’’ VAA, VLI, VGUL, Private VGUL I, Private APPLICANTS: E:\FR\FM\03APN1.SGM 03APN1

Agencies

[Federal Register Volume 79, Number 64 (Thursday, April 3, 2014)]
[Notices]
[Page 18739]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-07471]


=======================================================================
-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

[Release No. IC-30998]


Notice of Applications for Deregistration Under Section 8(f) of 
the Investment Company Act of 1940

March 28, 2014.
    The following is a notice of applications for deregistration under 
section 8(f) of the Investment Company Act of 1940 for the month of 
March 2014. A copy of each application may be obtained via the 
Commission's Web site by searching for the file number, or for an 
applicant using the Company name box, at https://www.sec.gov/search/search.htm or by calling (202) 551-8090. An order granting each 
application will be issued unless the SEC orders a hearing. Interested 
persons may request a hearing on any application by writing to the 
SEC's Secretary at the address below and serving the relevant applicant 
with a copy of the request, personally or by mail. Hearing requests 
should be received by the SEC by 5:30 p.m. on April 22, 2014, and 
should be accompanied by proof of service on the applicant, in the form 
of an affidavit or, for lawyers, a certificate of service. Hearing 
requests should state the nature of the writer's interest, the reason 
for the request, and the issues contested. Persons who wish to be 
notified of a hearing may request notification by writing to the 
Secretary, U.S. Securities and Exchange Commission, 100 F Street NE., 
Washington, DC 20549-1090.
    For Further Information Contact: Diane L. Titus at (202) 551-6810, 
SEC, Division of Investment Management, Chief Counsel's Office, 100 F 
Street NE., Washington, DC 20549-8010.

Lazard Alternative Strategies Fund, L.L.C. [File No. 811-10415]

    Summary: Applicant, a closed-end investment company, seeks an order 
declaring that it has ceased to be an investment company. Applicant 
transferred its assets to Lazard Alternative Strategies 1099 Fund, and 
on December 31, 2013, made a distribution to its shareholders based on 
net asset value. Expenses of $200,000 incurred in connection with the 
reorganization were paid by Lazard Asset Management LLC, applicant's 
investment adviser.
    Filing Dates: The application was filed on January 30, 2014, and 
amended on March 26, 2014.
    Applicant's Address: 30 Rockefeller Plaza, New York, NY 10112-6300.

Dreyfus Money Market Instruments Inc. [File No. 811-2557]

    Summary: Applicant seeks an order declaring that it has ceased to 
be an investment company. On March 7, 2013, applicant made a final 
liquidating distribution to its shareholders based on net asset value. 
Expenses of $1,897 incurred in connection with the reorganization were 
paid by The Dreyfus Corporation, applicant's investment adviser.
    Filing Dates: The application was filed on January 15, 2014, and 
amended on March 21, 2014.
    Applicant's Address: c/o The Dreyfus Corporation, 200 Park Ave., 
New York, NY 10166.

ING Emerging Markets Local Bond Fund [File No. 811-22505]; ING Global 
Strategic Income Fund [File No. 811-22681]

    Summary: Each applicant, a closed-end investment company, seeks an 
order declaring that it has ceased to be an investment company. 
Applicants have never made a public offering of their securities and do 
not propose to make a public offering or engage in business of any 
kind.
    Filing Date: The applications were filed on March 7, 2014.
    Applicants' Address: 7337 E Doubletree Ranch Rd., suite 100, 
Scottsdale, AZ 85258.

    For the Commission, by the Division of Investment Management, 
pursuant to delegated authority.
Kevin M. O'Neill,
Deputy Secretary.
[FR Doc. 2014-07471 Filed 4-2-14; 8:45 am]
BILLING CODE 8011-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.